Back to Startups

Sift Biosciences

Bioscience & Disease Healthcare Systems AI, ML, Gen AI
Bioscience & Disease Healthcare Systems AI, ML, Gen AI Show less
Bioscience & Disease Healthcare Systems +1
Bioscience & Disease Healthcare Systems AI, ML, Gen AI Show less
Website LinkedIn San Carlos, United States
About Sift Biosciences

Developing T-cell modulators for cancer treatment using AI, metagenomics, and high-throughput immune profiling.

Business Information
Target Customers
biopharmaceutical companies research institutions healthcare providers
Industry Categories
Bioscience & Disease Healthcare Systems AI, ML, Gen AI
Business Model
Revenue Model B2B
Pricing Strategy Custom pricing based on project scope
Sales Channels direct sales, partnerships with research institutions
Funding Timeline
Round Date Amount Investors
Pre-Seed Feb 19, 2026 $3.7M Lifespan Vision Ventures, @freeflow_zone
Founders
@
@ClareLou9

Founder & CEO

Investors
@
@freeflow_zone

Investor

L
Lifespan Vision Ventures

Venture Capital

Recent Mentions
startupraises
StartupRaises @startupraises
Feb 19, 2026

📣 Sift Biosciences secures $3.7M Pre-Seed Date: February 19, 2026 What they do: Developing T-cell modulators for cancer treatment. HQ: San Carlos, United States Sector: #Biotechnology #AI #HealthTech #Cancer Stage: Pre-Seed 🔗 https://t.co/gKv3s7nxRG

View on Twitter
raisingfi
Raising.fi @raisingfi
Feb 19, 2026

🏛️ Company: Sift Biosciences 🔗 Website: https://t.co/OsdLO7z8sX 📊 Amount: $3.7 Million 🔄 Round: Pre-Seed ⚙️ Industry: Biotechnology 🌍 Location: San Carlos, California, USA

View on Twitter
credx_club
CREDX @credx_club
Feb 20, 2026

Sift Biosciences: Sift Biosciences secured $3.7 million in pre-seed financing. The round was co-led by Lifespan Vision Ventures and will support the company's early-stage research and development in the biotechnology space.

View on Twitter
DevCuration
DevCuration @DevCuration
Feb 20, 2026

Sift Biosciences raised $3.7M in Pre-Seed from @freeflow_zone and Lifespan Vision Ventures to build an AI-powered peptide immunotherapy platform. @ClareLou9 is targeting immunologically cold tumors by activating memory T cells through metagenomics and immune profiling. https://t.co/S7aoSfw2Zc

View on Twitter
Similar Startups
Sifted
88% match

A self-serve platform for businesses to run targeted ads on streaming services.
inductive_bio
87% match

A platform that accelerates the discovery of life-changing therapeutics using state-of-the-art AI mo...
BioReact
87% match

A biotech startup focused on innovative solutions in the biotechnology sector, specializing in AI-po...
Think Bioscience
87% match

Think Bioscience is a biotechnology company focused on developing innovative solutions in the field ...